The Molecular Interaction Process

Area of Science:

• Biochemistry and Biophysics
• Pharmaceutical Sciences
• Chemical Engineering

Background:

• Noncovalent molecular interactions are fundamental thermodynamic processes governing biological systems.
• In biopharmaceuticals, these interactions are crucial for drug efficacy (target binding) but also cause manufacturing challenges like poor solubility and high viscosity.
• Protein-protein interactions are a key focus, with principles applicable to all solution-based interactions.

Purpose of the Study:

• To provide a foundational understanding of noncovalent interactions and their energetics.
• To explore the interplay between protein and solvent properties in determining interaction energetics.
• To elucidate the mechanisms behind protein aggregation, high viscosity, and emergent heterogeneity in biopharmaceutical formulations.

Main Methods:

• The commentary synthesizes existing knowledge on noncovalent interaction pathways.
• It analyzes the contributions of molecular and colloidal protein properties to interaction energetics.
• A model is presented to explain how noncontacting interactions can lead to high viscosity without affecting solubility.

Main Results:

• Noncovalent interactions follow common thermodynamic pathways.
• Both protein and solvent properties significantly influence the energetics of these interactions.
• Attractive interactions drive protein aggregation and viscosity, with emergent heterogeneity explaining high viscosity without low solubility.

Conclusions:

• A comprehensive understanding of noncovalent interactions is vital for biopharmaceutical development.
• The interplay of protein and solvent properties dictates interaction outcomes.
• The presented model offers insights into managing viscosity and formulation challenges in protein-based drugs.